T 1457/09 (CTL epitopes of WT-1/GANYMED PHARMACEUTICALS) of 17.01.2014

European Case Law Identifier: ECLI:EP:BA:2014:T145709.20140117
Date of decision: 17 January 2014
Case number: T 1457/09
Petition for review of: -
Application number: 99952682.5
IPC class: A61K 38/087 C07K 14/47 C07K 4/12 C07K 7/06
Language of proceedings: English
Distribution: Distributed to board chairmen (C)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: Immunotherapeutic methods using epitopes of WT-1 and GATA-1
Applicant name: Ganymed Pharmaceuticals AG
Opponent name: Dainippon Sumitomo Pharma Co., Ltd.
Board: 3.3.04
Headnote: -
Relevant legal provisions: European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 54(3)European Patent Convention Art 56 European Patent Convention Art 83 European Patent Convention Art 84Rules of procedure of the Boards of Appeal Art 13(3)
Keywords: Main request - after amendment: requirements of the EPC met (yes)
Catchword: See points 34 to 46
Cited cases: G 0002/98 G 0001/03 G 0002/10 T 0201/83 T 0609/02 T 1396/06 T 1437/07 T 0107/09
Citing cases: T 1452/16 T 0699/19 T 1203/19 T 2118/21

ORDER

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of the main request filed during the oral proceedings and a description and figures to be adapted thereto.